1,755 filings
Page 31 of 88
6-K
b894yly
7 Nov 14
Late Stage Data to be Presented at ACAAI 2014
12:00am
6-K
4c8nc5k9yz
7 Nov 14
Live Filing
12:00am
6-K
btiia
4 Nov 14
Live Filing
12:00am
6-K
4oydan2wp1ela5r1
30 Oct 14
Current report (foreign)
12:00am
6-K
ch2ejgybmhd
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
x0io9zu8y
8 Oct 14
Live Filing
12:00am
6-K
dhl4u
6 Oct 14
Live Filing
12:00am
6-K
dlhqlo2m 5eo9uq7
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
o92c2c 5a8ja9mo
12 Sep 14
Teva Presents Gene Expression Analysis at Joint ACTRIMS-ECTRIMS Meeting Demonstrating COPAXONE® (glatiramer acetate injection) Has a Complex Profile
12:00am
6-K
jx5 wlvzl1d5ee6167zr
12 Sep 14
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
12:00am
6-K
wdyr3zq kr8o
11 Sep 14
Live Filing
12:00am
6-K
28flgreht yms5p3
8 Sep 14
Successful Completion of Phase Iii Program for Teva’s Reslizumab
12:00am
6-K
nfsa0q ofx58
4 Sep 14
Teva to Present at the Morgan Stanley Global Healthcare Conference
12:00am
6-K
ozf6beivj
4 Sep 14
Teva Announces Launch of Generic Baraclude® TABLETS,0.5MG and 1MG, In the United States
12:00am
6-K
xjjonz35jht446
3 Sep 14
Live Filing
12:00am
6-K
gdu9 97eciw
3 Sep 14
Teva Launches Syncaretm Home Administration Support Program for Patients on Synribo® (Omacetaxine Mepesuccinate) for Injection
12:00am
6-K
nphco xv6a1bgutzk9g6
3 Sep 14
Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca
12:00am
6-K
bxfgxp5 gi057157
2 Sep 14
Live Filing
12:00am
6-K
kud14
7 Aug 14
Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation
12:00am
6-K
x4r acftwbx
31 Jul 14
Current report (foreign)
12:00am